Condensed Consolidated Statement of Operations - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|||||||||||
Net Sales: | ||||||||||||||
Net sales | $ 19,721 | $ 18,315 | $ 39,026 | $ 35,529 | ||||||||||
Costs and Expenses: | ||||||||||||||
Research and development | 706 | 729 | 1,375 | 1,336 | ||||||||||
Selling, general and administrative | 1,449 | 1,600 | 2,843 | 2,963 | ||||||||||
Total costs and expenses | 18,296 | 16,847 | 36,103 | 32,462 | ||||||||||
Other income (expense), net | (896) | 25 | (524) | 113 | ||||||||||
Operating profit | 529 | 1,493 | 2,399 | 3,180 | ||||||||||
Non-service pension income | (374) | (447) | (760) | (891) | ||||||||||
Interest expense, net | 475 | 333 | 880 | 648 | ||||||||||
Total non-operating expense (income), net | 101 | (114) | 120 | (243) | ||||||||||
Total Other Income Expenses | -748.0 | -666.0 | -1520.0 | -1296.0 | 0.0 | |||||||||
Total Other Income Expenses | 0.0 | 228.0 | 0.0 | 486.0 | 0.0 | |||||||||
Total Other Income Expenses | 202.0 | 0.0 | 240.0 | 0.0 | 0.0 | |||||||||
Total Other Income Expenses | 748.0 | 666.0 | 1520.0 | 1296.0 | 0.0 | |||||||||
Total Other Income Expenses | 0.0 | -228.0 | 0.0 | -486.0 | 0.0 | |||||||||
Total Other Income Expenses | -202.0 | 0.0 | -240.0 | 0.0 | 0.0 | |||||||||
Total Other Income Expenses | -950.0 | -894.0 | -1760.0 | -1782.0 | 0.0 | |||||||||
Total Other Income Expenses | 950.0 | 894.0 | 1760.0 | 1782.0 | 0.0 | |||||||||
Total Other Income Expenses | 202.0 | -228.0 | 240.0 | -486.0 | 0.0 | |||||||||
Income before income taxes | 428 | 1,607 | 2,279 | 3,423 | ||||||||||
Income tax expense | 253 | 248 | 361 | 583 | ||||||||||
Net income | 175 | 1,359 | 1,918 | 2,840 | ||||||||||
Less: Noncontrolling interest in subsidiaries’ earnings | 64 | 32 | 98 | 87 | ||||||||||
Net income attributable to common shareowners | $ 111 | $ 1,327 | $ 1,820 | $ 2,753 | ||||||||||
Earnings Per Share attributable to common shareowners: | ||||||||||||||
Basic | $ 0.08 | $ 0.91 | $ 1.37 | $ 1.89 | ||||||||||
Diluted | $ 0.08 | $ 0.90 | $ 1.36 | $ 1.87 | ||||||||||
Product [Member] | ||||||||||||||
Net Sales: | ||||||||||||||
Net sales | $ 14,562 | $ 13,411 | $ 28,865 | $ 26,198 | ||||||||||
Costs and Expenses: | ||||||||||||||
Cost of sales | 12,625 | 11,089 | 24,841 | 21,789 | ||||||||||
Service [Member] | ||||||||||||||
Net Sales: | ||||||||||||||
Net sales | 5,159 | 4,904 | 10,161 | 9,331 | ||||||||||
Costs and Expenses: | ||||||||||||||
Cost of sales | $ 3,516 | $ 3,429 | $ 7,044 | $ 6,374 |
X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|